BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28284518)

  • 1. Primary lymphoma of the female genital tract: An analysis of 697 cases.
    Nasioudis D; Kampaktsis PN; Frey M; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 May; 145(2):305-309. PubMed ID: 28284518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological features for primary lymphoma of the female genital tract patients and development of a nomogram to predict survival.
    Peng F; Li J; Mu S; Qin Y; Ma J; Ai L; Hu Y
    Ann Med; 2022 Dec; 54(1):962-976. PubMed ID: 35416104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
    Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
    Lei Y; Huang Q; Li X; Zheng X; Liu M
    Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
    Xiao M; Lin J; Xiao T; Lin Y; Ye Y
    Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal follicular lymphoma: using primary site as a predictor of survival.
    Chouhan J; Batra S; Gupta R; Guha S
    Cancer Med; 2016 Oct; 5(10):2669-2677. PubMed ID: 27696758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases.
    Nasioudis D; Alevizakos M; Chapman-Davis E; Witkin SS; Holcomb K
    Arch Gynecol Obstet; 2017 Aug; 296(2):327-334. PubMed ID: 28634755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Urinary Tract Lymphoma: Rare but Aggressive.
    Lontos K; Tsagianni A; Msaouel P; Appleman LJ; Nasioudis D
    Anticancer Res; 2017 Dec; 37(12):6989-6995. PubMed ID: 29187485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma.
    Khullar K; Plascak JJ; Drachtman R; Cole PD; Parikh RR
    Cancer Med; 2021 Feb; 10(4):1327-1334. PubMed ID: 33503323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
    Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
    Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis.
    Li S; Wang Z; Wu Z; Zhuang H; Xu Y
    Ann Hematol; 2019 Sep; 98(9):2111-2119. PubMed ID: 31227873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
    Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
    Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
    Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
    Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.